We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ENGNW

Price
2.90
Stock movement down
-0.06 (-2.03%)
Company name
enGene Holdings Inc. Warrants
Exchange
(NASDAQ
,
Currency
USD
)
Market cap
-
Ent value
3.61M
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-
3 year return
-
5 year return
-
10 year return
-
Last updated: 2026-01-08

DIVIDENDS

ENGNW does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count-
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash50.15M
Net receivables2.23M
Total current assets201.39M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment12.30M
Total assets221.47M
Accounts payable6.69M
Short/Current long term debt31.80M
Total current liabilities31.98M
Total liabilities53.76M
Shareholder's equity167.71M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.00
Daily high3.00
Daily low2.90
Daily Volume2K
All-time high6.38
1y analyst estimate-
Beta-0.27
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ENGNWS&P500
Current price drop from All-time high-54.55%-0.33%
Highest price drop-91.82%-19.00%
Date of highest drop9 Apr 20258 Apr 2025
Avg drop from high-80.03%-2.54%
Avg time to new high-6 days
Max time to new high241 days89 days
COMPANY DETAILS
ENGNW (enGene Holdings Inc. Warrants) company logo
Marketcap
-
Marketcap category
Small-cap
Description
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.
Employees
81
Investor relations
-
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner